BUY SHPG
Undervalued!
At least 9% long term return
Nice chance to buy a 10x 2018 earning company, growing around 10% for the next years.
Biopharma sector should be trading around 14x earning with growings around 3,5% a year.
At least 9% long term return
Nice chance to buy a 10x 2018 earning company, growing around 10% for the next years.
Biopharma sector should be trading around 14x earning with growings around 3,5% a year.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.